BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

AVAX Technologies, Inc. 

4520 Main Street, Suite 930

Kansas City  Missouri  64111  U.S.A.
Phone: 816-960-1333 Fax: 816-960-1334


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
AVAX Technologies, Inc. (AVXT) Announces Expansion Of Clinical Study With Autologous Ovarian Cancer Vaccine (Ovax®) 2/11/2014 10:01:21 AM    More...
AVAX Technologies, Inc. (AVXT) Files Form 10 With SEC 2/4/2011 11:20:30 AM    More...
AVAX Technologies, Inc. (AVXT) Closes Bridge Financing 12/17/2009 8:29:20 AM    More...
VasoGenix Pharmaceuticals, Inc. Elects Former AVAX Technologies, Inc. (AVXT) CEO Richard P. Rainey to Its Board of Directors 2/3/2009 11:24:37 AM    More...
AVAX Technologies, Inc. (AVXT) Announces Closing of Bridge Loan Financing 10/31/2008 11:25:39 AM    More...
AVAX Technologies, Inc. (AVXT) Presents Results of a Dose-Response Study of MVax(R) at American Society of Clinical Oncology 6/3/2008 2:37:20 PM    More...
AVAX Technologies, Inc. (AVXT) Announces Initiation of Clinical Study with Autologous Ovarian Cancer Vaccine (OVax(R)) 4/9/2008 7:04:47 AM    More...
AVAX Technologies, Inc. (AVXT) Appoints Chief Medical Officer for EMEA 3/31/2008 9:02:33 AM    More...
AVAX Technologies, Inc. (AVXT) to Present Results of Phase I-II Study of MVax(R) at 2008 Meeting of the American Society of Clinical Oncology 3/24/2008 9:29:40 AM    More...
AVAX Technologies, Inc. (AVXT) Announces Successful Completion of Phase I / II Study of MVax(R) in Patients with Stage 3 and 4 Melanoma 12/11/2007 1:16:04 PM    More...
1234